- Home
- WALD vs KRMD Comparison
WALD vs KRMD Comparison
Compare WALD & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WALD | KRMD |
|---|---|---|
| Founded | 1988 | 1980 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 192.5M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WALD | KRMD |
|---|---|---|
| Price | $1.29 | $3.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.00 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 305.3K | 261.6K |
| Earning Date | 03-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $9.89 | $20.32 |
| Revenue Next Year | $4.31 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $0.72 | $3.21 |
| 52 Week High | $3.22 | $6.61 |
Technical Indicators
Market Signals| Indicator | WALD | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 31.06 |
| Support Level | $1.23 | $3.21 |
| Resistance Level | $1.85 | $4.27 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 4.90 | 6.14 |
Price Performance
Historical ComparisonAbout WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.